In patients with erosive esophagitis (EE), treatment with NEXIUM provided day and night symptom relief1–3
*Heartburn-free defined as patient-recorded symptom of “none.”
†Secondary end points from 4 multicenter, randomized, double-blind trials comparing oral doses of NEXIUM vs omeprazole, administered once daily to patients with endoscopically diagnosed EE. Primary end point was healing of EE at week 8 (N=2425),1 (N=1960),2 (N=1148),3 (N=1175).4
NEXIUM 20 mg is the FDA-approved dose for the symptom relief of GERD.
NEXIUM 40 mg and NEXIUM 20 mg are the FDA-approved doses for the healing of EE. There is no correlation between symptom relief and the healing of EE with NEXIUM.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.